Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Prognostic scoring system after transplantation in myeloma: predicting early relapse

Meral Beksac, MD, Ankara University, Ankara, Turkey, outlines early relapse post-transplant as a poor prognostic feature in multiple myeloma. Dr Beksac highlights the results of a predictive study evaluating a prognostic scoring system after transplantation in multiple myeloma in order to predict early relapse. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Disclosures

Meral Beksac, MD, is on the advisory board and/or the speakers bureau for Amgen, BMS, Janssen, Sanofi, Takeda and Oncopeptides.